Literature DB >> 14633674

The contribution of genetic and epigenetic mechanisms to gene silencing in oligodendrogliomas.

Chibo Hong1, Andrew W Bollen, Joseph F Costello.   

Abstract

Very little is known of the genes and mechanisms contributing to the genesis of oligodendrogliomas, a subtype of primary brain tumors. Using an integrated genetic and epigenetic analysis of oligodendrogliomas, we show that aberrant CpG island methylation is the most prevalent alteration in these tumors, and the majority of methylated genes are independent of regions affected by deletion. In contrast, a subset of the gene-associated CpG islands are preferentially affected by converging methylation and deletion, including a putative zinc finger gene, ZNF342, located in a commonly deleted region at chromosome 19q13. ZNF342 expression is specifically decreased in primary oligodendrogliomas and up-regulated in glioma cell lines treated with a demethylating agent, whereas the expression level of the adjacent gene, Gemin7, is not consistently altered in these samples. This initial integrated approach identifies novel targets of gene silencing, and provides a more comprehensive view of the genes and mechanisms underlying oligodendrogliomas.

Entities:  

Mesh:

Year:  2003        PMID: 14633674

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Epigenetic silencing of the protocadherin family member PCDH-gamma-A11 in astrocytomas.

Authors:  Anke Waha; Stefanie Güntner; Tim Hui-Ming Huang; Pearlly S Yan; Bülent Arslan; Torsten Pietsch; Otmar D Wiestler; Andreas Waha
Journal:  Neoplasia       Date:  2005-03       Impact factor: 5.715

2.  Mutations in NSUN2 cause autosomal-recessive intellectual disability.

Authors:  Lia Abbasi-Moheb; Sara Mertel; Melanie Gonsior; Leyla Nouri-Vahid; Kimia Kahrizi; Sebahattin Cirak; Dagmar Wieczorek; M Mahdi Motazacker; Sahar Esmaeeli-Nieh; Kirsten Cremer; Robert Weißmann; Andreas Tzschach; Masoud Garshasbi; Seyedeh S Abedini; Hossein Najmabadi; H Hilger Ropers; Stephan J Sigrist; Andreas W Kuss
Journal:  Am J Hum Genet       Date:  2012-04-26       Impact factor: 11.025

3.  DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression.

Authors:  Shichun Zheng; E Andres Houseman; Zachary Morrison; Margaret R Wrensch; Joseph S Patoka; Christian Ramos; Daphne A Haas-Kogan; Sean McBride; Carmen J Marsit; Brock C Christensen; Heather H Nelson; David Stokoe; Joseph L Wiemels; Susan M Chang; Michael D Prados; Tarik Tihan; Scott R Vandenberg; Karl T Kelsey; Mitchel S Berger; John K Wiencke
Journal:  Neuro Oncol       Date:  2011-03       Impact factor: 12.300

4.  DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer.

Authors:  Yuya Kobayashi; Devin M Absher; Zulfiqar G Gulzar; Sarah R Young; Jesse K McKenney; Donna M Peehl; James D Brooks; Richard M Myers; Gavin Sherlock
Journal:  Genome Res       Date:  2011-04-26       Impact factor: 9.043

Review 5.  Pathology and molecular genetics of oligodendroglial tumors.

Authors:  Christian Hartmann; Wolf Mueller; Andreas von Deimling
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

Review 6.  Molecular profiling of oligodendrogliomas: impact on prognosis, treatment, and future directions.

Authors:  Douglas E Ney; Andrew B Lassman
Journal:  Curr Oncol Rep       Date:  2009-01       Impact factor: 5.075

Review 7.  Molecular background of oligodendroglioma: 1p/19q, IDH, TERT, CIC and FUBP1.

Authors:  Daniel P Cahill; David N Louis; John Gregory Cairncross
Journal:  CNS Oncol       Date:  2015-11-06

8.  Epigenetic silencing of the kinase tumor suppressor WNK2 is tumor-type and tumor-grade specific.

Authors:  Peter Jun; Chibo Hong; Anita Lal; Judith M Wong; Michael W McDermott; Andrew W Bollen; Christoph Plass; William A Held; Dominic J Smiraglia; Joseph F Costello
Journal:  Neuro Oncol       Date:  2008-11-11       Impact factor: 12.300

Review 9.  Molecular neuropathology of gliomas.

Authors:  Markus J Riemenschneider; Guido Reifenberger
Journal:  Int J Mol Sci       Date:  2009-01-07       Impact factor: 6.208

10.  Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses.

Authors:  Artemis P Vogazianou; Raymond Chan; L Magnus Bäcklund; Danita M Pearson; Lu Liu; Cordelia F Langford; Simon G Gregory; V Peter Collins; Koichi Ichimura
Journal:  Neuro Oncol       Date:  2010-02-17       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.